エーザイ：FDA grants accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease - 有報キャッチャー

エーザイ（4523）　FDA grants accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease 2021/06/08

/-

読み込み中…